Annexin Pharmaceuticals AB
3 clinical trials · Sponsor
◉ Watch Annexin Pharmaceuticals AB
| Record | Firm | Date |
|---|---|---|
| Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Diabetic Retinopathy or Retinal Vein Occlusion (NCT07259928) | Annexin Pharmaceuticals AB | 2025-11-07 |
| Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Retinal Vein Occlusion (NCT05532735) | Annexin Pharmaceuticals AB | 2022-08-24 |
| First in Human Study of ANXV (Recombinant Human Annexin A5) in Healthy Volunteers (NCT04850339) | Annexin Pharmaceuticals AB | 2020-12-21 |
Track Annexin Pharmaceuticals AB automatically
Every clearance here is in the API, with alerts when new ones post.